PACT Pharma is an exciting, well-funded clinical-stage biotechnology company developing personalized adoptive T cell therapies for the eradication of solid tumors.
Location: United States, California, South San Francisco
Employees: 201-500
Phone: +1 650-597-9500
Total raised: $75M
Founded date: 2016
Investors 7
| Date | Name | Website |
| - | Vida Ventu... | vidaventur... |
| - | Droia Onco... | droiaventu... |
| - | Taiho Vent... | taihoventu... |
| - | UpHonest C... | uphonestca... |
| - | Canaan Par... | canaan.com |
| - | GV | gv.com |
| - | Pontifax V... | pontifax.c... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 13.01.2020 | Series C | $75M | - |
Mentions in press and media 7
| Date | Title | Description | Source |
| 05.03.2021 | PACT Pharma Announces Planned Retirement of CEO Alex Franzus... | SOUTH SAN FRANCISCO, Calif., March 5, 2021 /PRNewswire/ -- PACT Pharma, Inc., a clinical-stage compa... | oaoa.com/n... |
| 05.03.2021 | PACT Pharma Announces Planned Retirement of CEO Alex Franzus... | SOUTH SAN FRANCISCO, Calif., March 5, 2021 /PRNewswire/ -- PACT Pharma, Inc., a clinical-stage com... | prnewswire... |
| 13.01.2020 | PACT Pharma Secures $75M in Series C Financing | PACT Pharma, a SouthSan Francisco, Calif.-based advancing personalized NeoTCR-T cell therapies to er... | finsmes.co... |
| 10.01.2020 | PACT Pharma Raises $75M in Oversubscribed Series C Financing... | - | vidaventur... |
| 22.07.2019 | Pact Pharma enrolls first patients in Phase Ia/Ib solid tumo... | “These exciting results open a bold new frontier for directing a person’s own immune system to treat... | medcitynew... |
| 20.09.2017 | Arcus' cancer portfolio attracts $35M option deal from Japan... | Immuno-oncology startup Arcus Bioscience has signed a deal with Japanese drugmaker Taiho that provid... | fiercebiot... |
| - | Pact Pharma enrolls first patients in Phase Ia/Ib solid tumo... | A company developing cell therapies in oncology has started dosing patients in an early-stage clinic... | medcitynew... |